Lily Yan, MBA, MS, CPA, is an experienced finance professional specializing in financial planning and analysis. Currently serving as the Director of Financial Planning and Analysis at Ardelyx, Inc. since October 2025, Lily has held significant roles at Flagship Pioneering from 2022 to 2025 and at Eisai US from 2018 to 2022, where responsibilities included Associate Director of Finance and Senior Manager of R&D Finance. Prior experience includes managerial positions at Bioverativ, which was acquired by Sanofi in 2018, as well as various senior analyst roles at Shire and Alkermes. Lily holds an MBA in Management/Finance and an MS in Accounting, both from the University of Connecticut.
This person is not in any teams
This person is not in any offices